Lannett Company buys manufacturer and marketer of liquid generic pharmaceutical products.
Lannett Co. on Monday announced that its abbreviated new drug application for oxycodone hydrochloride capsules, 5 mg, has been approved by the Food and Drug Administration.
Lannett Co. received approval from the Food and Drug Administration for codeine sulfate tablets USP, a schedule II controlled substance, in 15 mg, 30 mg and 60 mg dosage strengths.
The Food and Drug Administration has approved a generic drug for obesity made by Lannett, the drug maker said Tuesday.
Lannett announced that it has started shipping morphine sulfate oral solution, a painkiller approved by the Food and Drug Administration in June.